Found: 18
Select item for more details and to access through your institution.
Effects of strong and moderate CYP3A4 inducers on the pharmacokinetics of fedratinib in healthy adult participants.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 369, doi. 10.1007/s00280-021-04292-4
- By:
- Publication type:
- Article
Evaluation of two software using Bayesian methods for monitoring exposure and dosing once-daily intravenous busulfan in paediatric patients receiving haematopoietic stem cell transplantation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 379, doi. 10.1007/s00280-021-04288-0
- By:
- Publication type:
- Article
Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 393, doi. 10.1007/s00280-021-04277-3
- By:
- Publication type:
- Article
Phase I study of liposomal irinotecan (LY01610) in patients with advanced esophageal squamous cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 403, doi. 10.1007/s00280-021-04294-2
- By:
- Publication type:
- Article
A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 415, doi. 10.1007/s00280-021-04298-y
- By:
- Publication type:
- Article
Dabrafenib and trametinib exposure-efficacy and tolerance in metastatic melanoma patients: a pharmacokinetic–pharmacodynamic real-life study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 427, doi. 10.1007/s00280-021-04299-x
- By:
- Publication type:
- Article
Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 439, doi. 10.1007/s00280-021-04301-6
- By:
- Publication type:
- Article
Mechanistic physiology-based pharmacokinetic modeling to elucidate vincristine-induced peripheral neuropathy following treatment with novel kinase inhibitors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 451, doi. 10.1007/s00280-021-04302-5
- By:
- Publication type:
- Article
A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 465, doi. 10.1007/s00280-021-04297-z
- By:
- Publication type:
- Article
Feasibility of pharmacometabolomics to identify potential predictors of paclitaxel pharmacokinetic variability.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 485, doi. 10.1007/s00280-021-04308-z
- By:
- Publication type:
- Article
Population pharmacokinetic and exploratory exposure–response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 499, doi. 10.1007/s00280-021-04296-0
- By:
- Publication type:
- Article
Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 513, doi. 10.1007/s00280-021-04310-5
- By:
- Publication type:
- Article
Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 525, doi. 10.1007/s00280-021-04304-3
- By:
- Publication type:
- Article
Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 533, doi. 10.1007/s00280-021-04307-0
- By:
- Publication type:
- Article
Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 543, doi. 10.1007/s00280-021-04314-1
- By:
- Publication type:
- Article
Panobinostat penetrates the blood–brain barrier and achieves effective brain concentrations in a murine model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 555, doi. 10.1007/s00280-021-04313-2
- By:
- Publication type:
- Article
Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice